Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chabot

Showing results (71-80 of 175) with videos related to

Pageof 18
Sort By:
Synapse (New York, N.Y.)|June 1, 1992
Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2)D Michel, J G Chabot, E Moyse, et al.
Experimental Cell Research|January 1, 1989
Presence of angiotensin II in the adult male rat anterior pituitary gland: immunocytochemical study after cryoultramicrotomyJ G Chabot, D A Gray, P M Dubois, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 1998
Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptorW Zhu, P J Malloy, E Delvin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 7, 2012
Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumoursJohanne Seguin, Céline Nicolazzi, Nathalie Mignet, et al.
Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patientsG G Chabot, L E Flaherty, M Valdivieso, et al.
Neuroscience|October 1, 1997
Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formationS Kar, D Seto, S Doré, et al.
Current Drug Metabolism|February 7, 2003
Retinoic acid metabolism and mechanism of action: a reviewJulie Marill, Nadia Idres, Claude C Capron, et al.
Cancer Research|February 24, 2001
Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolitesN Idres, G Benoît, M A Flexor, et al.
Biochimie|July 1, 1984
[Epidermal growth factor: structure, location, phosphorylation and regulation of its receptor]R St-Arnaud, J G Chabot, G Pelletier, et al.
Pageof 18

Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Synapse (New York, N.Y.)|June 1, 1992
Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2)D Michel, J G Chabot, E Moyse, et al.
Experimental Cell Research|January 1, 1989
Presence of angiotensin II in the adult male rat anterior pituitary gland: immunocytochemical study after cryoultramicrotomyJ G Chabot, D A Gray, P M Dubois, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 1998
Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptorW Zhu, P J Malloy, E Delvin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 7, 2012
Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumoursJohanne Seguin, Céline Nicolazzi, Nathalie Mignet, et al.
Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patientsG G Chabot, L E Flaherty, M Valdivieso, et al.
Neuroscience|October 1, 1997
Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formationS Kar, D Seto, S Doré, et al.
Current Drug Metabolism|February 7, 2003
Retinoic acid metabolism and mechanism of action: a reviewJulie Marill, Nadia Idres, Claude C Capron, et al.
Cancer Research|February 24, 2001
Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolitesN Idres, G Benoît, M A Flexor, et al.
Biochimie|July 1, 1984
[Epidermal growth factor: structure, location, phosphorylation and regulation of its receptor]R St-Arnaud, J G Chabot, G Pelletier, et al.
Pageof 18